MENU
SER
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION
Serina Therapeutics (SER) Ownership - Who owns Serina Therapeutics?
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain... Show more
Profile
Industry
N/A
Address
601 Genome Way
Phone
+1 256 327-0566
Employees
N/A
Web
https://www.serinatherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
54.53M
P/E Ratio
1.51
Total Cash
6.04M
Projected Growth
N/A
Total Debt
185K
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.59
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
SER
Capitalization
54.5M
P/E Ratio
1.51
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
6.04M
Total Cash/Share
0.59
Total Debt
185K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
-3.14M
P/B Ratio
29.85
Cash Flow
N/A
Earnings
-0.92
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1K
Current Ratio
2.24
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-12.47M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-128.16
Shares Held By Institutions
3.09M
Shares Outstanding - Current
10.3M
Total Liabilities
7.3M
Total Volume MTD
N/A
Value
-1
Gain YTD
6.188
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
601 Genome Way
Phone
+1 256 327-0566
Employees
N/A
Web
https://www.serinatherapeutics.com